QuantRX Biomedical Corp. (OTCMKTS:QTXB) Lures Investors After Promotion

Yesterday QuantRX Biomedical Corp. (OTCMKTS:QTXB), a mostly dead ticker that has seen only a couple of days with active trading since the start of the year, decided that its time for a revival. They opened at $0.09 and quickly surged up to $0.139 – an increase of more than 670% compared to the previous close making it their 52-week high. The early morning enthusiasm quickly faded away though and at closing time the stock had already slid down to $0.04.

The sad part for investors who decided to jump in while the prices were still high is that the chances of them ever getting a profit from QTXB are quite slim. A second movement like yesterday’s is extremely unlikely to happen. And the number of bag holders is quite high seeing how the traded volume exploded from 600 on Monday to 4.6 million on Tuesday.

The main reason that sparked interest in the stock, in the absence of any formal news announcements, must be the emails send by Darth Trader and The Stock Psycho. They are amongst the more influential newsletters and it certainly showed. Disclosing no compensation for their services they still managed to convince unprecedented amount of traders, who by now must be lamenting the decision to invest in the stock.

That is why we always encourage you to do your due diligence and check the underlying fundamentals of any company that you are considering. Looking at the financials of the QTXB, it becomes quite clear that they are not a sound choice for investment. The latest report is for the quarter ending March 31 and it contained:

• $4.991 cash
• $226 thousand total current assets
• $849 thousand total current liabilities
• $3341 revenues
• $40 thousand net loss

QTXB is trying to sell its innovative PAD based products for the OTC and laboratory markets and its genomic diagnostics, based on its patented PadKit technology for the worldwide healthcare industry. The problem is that they still have a long way to go as it is quite evident that they don’t have the required funds to execute their business plan. They don’t even have an official site yet because when we tried to open it the only thing to greet us was a nice “Under Construction” sign.

Another disastrous pump for both Darth Trader and The Stock Psycho was that of UOMO Media, Inc. (OTCMKTS:UOMO). They bagged the hefty sum of $150 000 while the ticker bombed by 46% on the first day of touting.

We cannot stress enough how important it is to do your own research before committing to any trades.
Losses can’t always be avoided but at least you would know what you are stepping into and you can decide on an adequate time horizon for you investment.